Report Detail

Pharma & Healthcare Global Psoriasis Treatment Drugs Market Research Report 2022

  • RnM4454882
  • |
  • 20 June, 2022
  • |
  • Global
  • |
  • 100 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Industry Insights
The global Psoriasis Treatment Drugs market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, TNF Inhibitors accounting for % of the Psoriasis Treatment Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Oral segment is altered to an % CAGR throughout this forecast period.

China Psoriasis Treatment Drugs market size is valued at US$ million in 2021, while the North America and Europe Psoriasis Treatment Drugs are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Psoriasis Treatment Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Psoriasis Treatment Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Psoriasis Treatment Drugs market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Psoriasis Treatment Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Psoriasis Treatment Drugs market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Psoriasis Treatment Drugs market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Psoriasis Treatment Drugs Breakdown Data by Type

TNF Inhibitors

Interleukin Inhibitors

Vitamin D Analogs

Corticosteroids

Others

Psoriasis Treatment Drugs Breakdown Data by Application

Oral

Parenteral

Topical

Regional Analysis

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Amgen

Allergan

Dermira

Eli Lilly

Novartis

Merck

Johnson & Johnson

Pfizer

AstraZeneca

AbbVie

LEO Pharma

Biogen

Galectin Therapeutics

Cellceutix

Bayer

Frequently Asked Questions

What factors will challenge the Psoriasis Treatment Drugs market growth?

Which end-use segment will expand at the fastest CAGR in the Psoriasis Treatment Drugs market?

Which are the emerging players in the Psoriasis Treatment Drugs market?

How concentrated is the Psoriasis Treatment Drugs market?

Which factors are positively contributing to the Psoriasis Treatment Drugs market growth?

Which are the novel product innovations in the Psoriasis Treatment Drugs market?

Which product segment will emerge as the most lucrative in the Psoriasis Treatment Drugs market?

Which factors are increasing the competition in the Psoriasis Treatment Drugs market?

Which are the strategic measures taken by the Psoriasis Treatment Drugs industry players?

Which region will witness inactive growth during the forecast period?

What key trends are likely to emerge in the Psoriasis Treatment Drugs market in the coming years?


1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
  • 1.2.1 Global Psoriasis Treatment Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
  • 1.2.2 TNF Inhibitors
  • 1.2.3 Interleukin Inhibitors
  • 1.2.4 Vitamin D Analogs
  • 1.2.5 Corticosteroids
  • 1.2.6 Others
  • 1.3 Market by Application
  • 1.3.1 Global Psoriasis Treatment Drugs Market Share by Application: 2017 VS 2021 VS 2028
  • 1.3.2 Oral
  • 1.3.3 Parenteral
  • 1.3.4 Topical
  • 1.4 Study Objectives
  • 1.5 Years Considered
  • 2 Global Growth Trends

    • 2.1 Global Psoriasis Treatment Drugs Market Perspective (2017-2028)
    • 2.2 Psoriasis Treatment Drugs Growth Trends by Region
    • 2.2.1 Psoriasis Treatment Drugs Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Psoriasis Treatment Drugs Historic Market Size by Region (2017-2022)
  • 2.2.3 Psoriasis Treatment Drugs Forecasted Market Size by Region (2023-2028)
  • 2.3 Psoriasis Treatment Drugs Market Dynamics
  • 2.3.1 Psoriasis Treatment Drugs Industry Trends
  • 2.3.2 Psoriasis Treatment Drugs Market Drivers
  • 2.3.3 Psoriasis Treatment Drugs Market Challenges
  • 2.3.4 Psoriasis Treatment Drugs Market Restraints
  • 3 Competition Landscape by Key Players

    • 3.1 Global Top Psoriasis Treatment Drugs Players by Revenue
    • 3.1.1 Global Top Psoriasis Treatment Drugs Players by Revenue (2017-2022)
  • 3.1.2 Global Psoriasis Treatment Drugs Revenue Market Share by Players (2017-2022)
  • 3.2 Global Psoriasis Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Psoriasis Treatment Drugs Revenue
  • 3.4 Global Psoriasis Treatment Drugs Market Concentration Ratio
  • 3.4.1 Global Psoriasis Treatment Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Treatment Drugs Revenue in 2021
  • 3.5 Psoriasis Treatment Drugs Key Players Head office and Area Served
  • 3.6 Key Players Psoriasis Treatment Drugs Product Solution and Service
  • 3.7 Date of Enter into Psoriasis Treatment Drugs Market
  • 3.8 Mergers & Acquisitions, Expansion Plans
  • 4 Psoriasis Treatment Drugs Breakdown Data by Type

    • 4.1 Global Psoriasis Treatment Drugs Historic Market Size by Type (2017-2022)
    • 4.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Type (2023-2028)

    5 Psoriasis Treatment Drugs Breakdown Data by Application

    • 5.1 Global Psoriasis Treatment Drugs Historic Market Size by Application (2017-2022)
    • 5.2 Global Psoriasis Treatment Drugs Forecasted Market Size by Application (2023-2028)

    6 North America

    • 6.1 North America Psoriasis Treatment Drugs Market Size (2017-2028)
    • 6.2 North America Psoriasis Treatment Drugs Market Size by Country (2017-2022)
    • 6.3 North America Psoriasis Treatment Drugs Market Size by Country (2023-2028)
    • 6.4 United States
    • 6.5 Canada

    7 Europe

    • 7.1 Europe Psoriasis Treatment Drugs Market Size (2017-2028)
    • 7.2 Europe Psoriasis Treatment Drugs Market Size by Country (2017-2022)
    • 7.3 Europe Psoriasis Treatment Drugs Market Size by Country (2023-2028)
    • 7.4 Germany
    • 7.5 France
    • 7.6 U.K.
    • 7.7 Italy
    • 7.8 Russia
    • 7.9 Nordic Countries

    8 Asia-Pacific

    • 8.1 Asia-Pacific Psoriasis Treatment Drugs Market Size (2017-2028)
    • 8.2 Asia-Pacific Psoriasis Treatment Drugs Market Size by Country (2017-2022)
    • 8.3 Asia-Pacific Psoriasis Treatment Drugs Market Size by Country (2023-2028)
    • 8.4 China
    • 8.5 Japan
    • 8.6 South Korea
    • 8.7 Southeast Asia
    • 8.8 India
    • 8.9 Australia

    9 Latin America

    • 9.1 Latin America Psoriasis Treatment Drugs Market Size (2017-2028)
    • 9.2 Latin America Psoriasis Treatment Drugs Market Size by Country (2017-2022)
    • 9.3 Latin America Psoriasis Treatment Drugs Market Size by Country (2023-2028)
    • 9.4 Mexico
    • 9.5 Brazil

    10 Middle East & Africa

    • 10.1 Middle East & Africa Psoriasis Treatment Drugs Market Size (2017-2028)
    • 10.2 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2017-2022)
    • 10.3 Middle East & Africa Psoriasis Treatment Drugs Market Size by Country (2023-2028)
    • 10.4 Turkey
    • 10.5 Saudi Arabia
    • 10.6 UAE

    11 Key Players Profiles

    • 11.1 Amgen
    • 11.1.1 Amgen Company Detail
  • 11.1.2 Amgen Business Overview
  • 11.1.3 Amgen Psoriasis Treatment Drugs Introduction
  • 11.1.4 Amgen Revenue in Psoriasis Treatment Drugs Business (2017-2022)
  • 11.1.5 Amgen Recent Development
  • 11.2 Allergan
  • 11.2.1 Allergan Company Detail
  • 11.2.2 Allergan Business Overview
  • 11.2.3 Allergan Psoriasis Treatment Drugs Introduction
  • 11.2.4 Allergan Revenue in Psoriasis Treatment Drugs Business (2017-2022)
  • 11.2.5 Allergan Recent Development
  • 11.3 Dermira
  • 11.3.1 Dermira Company Detail
  • 11.3.2 Dermira Business Overview
  • 11.3.3 Dermira Psoriasis Treatment Drugs Introduction
  • 11.3.4 Dermira Revenue in Psoriasis Treatment Drugs Business (2017-2022)
  • 11.3.5 Dermira Recent Development
  • 11.4 Eli Lilly
  • 11.4.1 Eli Lilly Company Detail
  • 11.4.2 Eli Lilly Business Overview
  • 11.4.3 Eli Lilly Psoriasis Treatment Drugs Introduction
  • 11.4.4 Eli Lilly Revenue in Psoriasis Treatment Drugs Business (2017-2022)
  • 11.4.5 Eli Lilly Recent Development
  • 11.5 Novartis
  • 11.5.1 Novartis Company Detail
  • 11.5.2 Novartis Business Overview
  • 11.5.3 Novartis Psoriasis Treatment Drugs Introduction
  • 11.5.4 Novartis Revenue in Psoriasis Treatment Drugs Business (2017-2022)
  • 11.5.5 Novartis Recent Development
  • 11.6 Merck
  • 11.6.1 Merck Company Detail
  • 11.6.2 Merck Business Overview
  • 11.6.3 Merck Psoriasis Treatment Drugs Introduction
  • 11.6.4 Merck Revenue in Psoriasis Treatment Drugs Business (2017-2022)
  • 11.6.5 Merck Recent Development
  • 11.7 Johnson & Johnson
  • 11.7.1 Johnson & Johnson Company Detail
  • 11.7.2 Johnson & Johnson Business Overview
  • 11.7.3 Johnson & Johnson Psoriasis Treatment Drugs Introduction
  • 11.7.4 Johnson & Johnson Revenue in Psoriasis Treatment Drugs Business (2017-2022)
  • 11.7.5 Johnson & Johnson Recent Development
  • 11.8 Pfizer
  • 11.8.1 Pfizer Company Detail
  • 11.8.2 Pfizer Business Overview
  • 11.8.3 Pfizer Psoriasis Treatment Drugs Introduction
  • 11.8.4 Pfizer Revenue in Psoriasis Treatment Drugs Business (2017-2022)
  • 11.8.5 Pfizer Recent Development
  • 11.9 AstraZeneca
  • 11.9.1 AstraZeneca Company Detail
  • 11.9.2 AstraZeneca Business Overview
  • 11.9.3 AstraZeneca Psoriasis Treatment Drugs Introduction
  • 11.9.4 AstraZeneca Revenue in Psoriasis Treatment Drugs Business (2017-2022)
  • 11.9.5 AstraZeneca Recent Development
  • 11.10 AbbVie
  • 11.10.1 AbbVie Company Detail
  • 11.10.2 AbbVie Business Overview
  • 11.10.3 AbbVie Psoriasis Treatment Drugs Introduction
  • 11.10.4 AbbVie Revenue in Psoriasis Treatment Drugs Business (2017-2022)
  • 11.10.5 AbbVie Recent Development
  • 11.11 LEO Pharma
  • 11.11.1 LEO Pharma Company Detail
  • 11.11.2 LEO Pharma Business Overview
  • 11.11.3 LEO Pharma Psoriasis Treatment Drugs Introduction
  • 11.11.4 LEO Pharma Revenue in Psoriasis Treatment Drugs Business (2017-2022)
  • 11.11.5 LEO Pharma Recent Development
  • 11.12 Biogen
  • 11.12.1 Biogen Company Detail
  • 11.12.2 Biogen Business Overview
  • 11.12.3 Biogen Psoriasis Treatment Drugs Introduction
  • 11.12.4 Biogen Revenue in Psoriasis Treatment Drugs Business (2017-2022)
  • 11.12.5 Biogen Recent Development
  • 11.13 Galectin Therapeutics
  • 11.13.1 Galectin Therapeutics Company Detail
  • 11.13.2 Galectin Therapeutics Business Overview
  • 11.13.3 Galectin Therapeutics Psoriasis Treatment Drugs Introduction
  • 11.13.4 Galectin Therapeutics Revenue in Psoriasis Treatment Drugs Business (2017-2022)
  • 11.13.5 Galectin Therapeutics Recent Development
  • 11.14 Cellceutix
  • 11.14.1 Cellceutix Company Detail
  • 11.14.2 Cellceutix Business Overview
  • 11.14.3 Cellceutix Psoriasis Treatment Drugs Introduction
  • 11.14.4 Cellceutix Revenue in Psoriasis Treatment Drugs Business (2017-2022)
  • 11.14.5 Cellceutix Recent Development
  • 11.15 Bayer
  • 11.15.1 Bayer Company Detail
  • 11.15.2 Bayer Business Overview
  • 11.15.3 Bayer Psoriasis Treatment Drugs Introduction
  • 11.15.4 Bayer Revenue in Psoriasis Treatment Drugs Business (2017-2022)
  • 11.15.5 Bayer Recent Development
  • 12 Analyst's Viewpoints/Conclusions

      13 Appendix

      • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
    • 13.2 Disclaimer
    • Summary:
      Get latest Market Research Reports on Psoriasis Treatment Drugs. Industry analysis & Market Report on Psoriasis Treatment Drugs is a syndicated market report, published as Global Psoriasis Treatment Drugs Market Research Report 2022. It is complete Research Study and Industry Analysis of Psoriasis Treatment Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,386.70
      4,773.40
      2,772.40
      5,544.80
      394,081.00
      788,162.00
      228,752.00
      457,504.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report